Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 24 October 2003:
Vol. 302. no. 5645, pp. 574 - 575
DOI: 10.1126/science.1091465
Prev | Table of Contents | Next

Perspectives

Also see the archival list of Science's Compass: Enhanced Perspectives

CANCER:
Enhanced: A Risky Business--Assessing Breast Cancer Risk

Ephrat Levy-Lahad and Sharon E. Plon

An analysis of BRCA1 and BRCA2 mutations in female relatives of carriers identified among 1008 breast cancer patients has provided revised estimates for the breast cancer risk associated with these mutations. In a Perspective, Levy-Lahad and Plon discuss these revised estimates reported by the New York Breast Cancer Study (King et al.) and what they reveal about the influence of nongenetic factors on breast cancer susceptibility.

E. Levy-Lahad is in the Medical Genetics Unit, Shaare Zedek Medical Center, Hebrew University, Jerusalem 91031, Israel. E-mail: lahad{at}szmc.org.il S. E. Plon is in the Department of Pediatrics and Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA. E-mail: splon{at}bcm.tmc.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Ethical Issues Related To BRCA Gene Testing in Orthodox Jewish Women.
P. Mor and K. Oberle (2008)
Nursing Ethics 15, 512-522
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)